Topical Collagen-Silver Versus Standard Care Following Removal of Ingrown Nails
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00641433|
Recruitment Status : Unknown
Verified March 2008 by Rosalind Franklin University of Medicine and Science.
Recruitment status was: Recruiting
First Posted : March 24, 2008
Last Update Posted : March 24, 2008
|Condition or disease||Intervention/treatment||Phase|
|Ingrown Nail||Device: oxidized regenerated cellulose collagen-silver Drug: topical silver sulfadiazine cream||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||80 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Topical Collagen-Silver Versus Standard Care Following Phenol Ablation of Ingrown Nails: A Randomized Controlled Trial|
|Study Start Date :||November 2005|
|Estimated Primary Completion Date :||May 2008|
|Estimated Study Completion Date :||May 2008|
Subjects will daily dress their nail bed with oxidized regenerated cellulose collagen-silver, until healing occurs.
Device: oxidized regenerated cellulose collagen-silver
Wound dressed daily with oxidized regenerated cellulose collagen-silver matrix.
Other Name: Prisma
Active Comparator: Control
Topical silver sulfadiazine cream will be applied daily to the wound bed until healing has occured.
Drug: topical silver sulfadiazine cream
Cream will be applied to nailbed daily and dressed with a bandage until healing occurs.
Other Name: Silvadene, Thermazene
- time to healing [ Time Frame: weekly ]
- time to return to regular shoe gear [ Time Frame: weekly ]
- days unable to work [ Time Frame: weekly ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00641433
|Contact: David G Armstrong, DPM, PhDemail@example.com|
|United States, Illinois|
|Scholl Foot and Ankle Center||Recruiting|
|North Chicago, Illinois, United States, 60064|
|Contact: Ryan T Crews, MS 847-578-8437 firstname.lastname@example.org|
|Principal Investigator: David Armstrong, DPM, PhD|
|Sub-Investigator: Stephanie Wu, DPM, MS|
|Sub-Investigator: James Wrobel, DPM, MS|
|United States, Virginia|
|Preofessional Education and Research Institutue||Recruiting|
|Roanoke, Virginia, United States, 24016|
|Contact: Charles Zelen, DPM 540-725-5027 email@example.com|
|Principal Investigator: Charles Zelen, DPM|
|Principal Investigator:||David G Armstrong, DPM, PhD||Rosalind Franklin University|